###begin article-title 0
###xml 0 6 <span type="species:ncbi:10090">Murine</span>
Murine Neural Stem/Progenitor Cells Protect Neurons against Ischemia by HIF-1alpha-Regulated VEGF Signaling
###end article-title 0
###begin p 1
Conceived and designed the experiments: KMH LL LAC. Performed the experiments: KMH LL LAC. Analyzed the data: KMH LL LAC. Contributed reagents/materials/analysis tools: KMH LAC. Wrote the paper: KMH LAC.
###end p 1
###begin p 2
###xml 449 456 449 456 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 461 469 461 469 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
Focal cerebral ischemia following middle cerebral artery occlusion (MCAO) stimulates a robust cytogenic response from the adult subventricular zone (SVZ) that includes massive proliferation of neural stem/progenitor cells (NSPCs) and cellular migration into the injury area. To begin to explore beneficial roles of NSPCs in this response, we investigated the ability of embryonic and postnatal NSPCs to promote neuronal survival under conditions of in vivo and in vitro ischemia. Intracerebral transplantation of NSPCs attenuated neuronal apoptosis in response to focal ischemia induced by transient MCAO, and prevented neuronal cell death of cortical neurons in response to oxygen-glucose deprivation (OGD) in culture. NSPC-mediated neuroprotection was blocked by the pharmacological inhibitors of vascular endothelial growth factor (VEGF), SU1498 and Flt-1Fc. Embryonic and postnatal NSPCs were both intrinsically resistant to brief OGD exposure, and constitutively expressed both hypoxia-inducible factor 1alpha (HIF-1alpha) transcription factor and its downstream target, VEGF. Genomic deletion of HIF-1alpha by Cre-mediated excision of exon 2 in NSPC cultures resulted in >50% reduction of VEGF production and ablation of NSPC-mediated neuroprotection. These findings indicate that NSPCs promote neuronal survival under ischemic conditions via HIF-1alpha-VEGF signaling pathways and support a role for NSPCs in promotion of neuronal survival following stroke.
###end p 2
###begin title 3
Introduction
###end title 3
###begin p 4
###xml 221 224 221 224 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0009767-Eriksson1">[1]</xref>
###xml 225 228 225 228 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0009767-AlvarezBuylla1">[4]</xref>
###xml 432 435 432 435 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0009767-Gage1">[2]</xref>
###xml 437 440 437 440 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0009767-McKay1">[5]</xref>
###xml 441 444 441 444 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0009767-Ivanova1">[7]</xref>
Two predominant neurogenic regions persist within the adult mammalian brain, located within the subgranular zone (SGZ) of the hippocampal dentate gyrus and the subventricular zone (SVZ) surrounding the lateral ventricles [1]-[4]. Neural stem/progenitor cells (NSPCs) that reside within these brain regions are mitotically active, self-renewing cells with the potential to differentiate into neurons, oligodendrocytes, or astrocytes [2], [5]-[7].
###end p 4
###begin p 5
###xml 155 158 155 158 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0009767-Jin1">[8]</xref>
###xml 159 163 159 163 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0009767-Yamashita1">[14]</xref>
###xml 321 325 321 325 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0009767-Maysami1">[15]</xref>
###xml 444 448 444 448 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0009767-Kondziolka1">[16]</xref>
###xml 450 454 450 454 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0009767-Zhang2">[17]</xref>
###xml 666 670 666 670 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0009767-Kokaia1">[18]</xref>
###xml 1051 1055 1051 1055 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0009767-Burns1">[19]</xref>
###xml 148 154 <span type="species:ncbi:9606">humans</span>
Following focal cerebral ischemia, neural stem/progenitor cells (NSPCs) in the SVZ proliferate and migrate to the lesioned site in both rodents and humans [8]-[14]. Migration of NSPCs and their progeny may be critical for post-ischemic repair, since ablation of progenitor proliferation leads to increased infarct volume [15] and the time course of this migratory response occurs concomitant with partial spontaneous recovery of motor deficits [16], [17]. Although hundreds of thousands of cells emigrate from the SVZ into the injured striatal parenchyma, the number of neuroblasts that survive long-term represents <0.2% of striatal neurons lost to ischemic injury [18]. That such a low number of new neurons contribute significantly to the reconstruction of striatal circuitry seems unlikely. Nevertheless, evidence suggests that SVZ derivatives migrating into the injured striatal parenchyma contribute importantly to the process of endogenous wound healing following ischemic insult, through processes apart or in addition to neuronal replacement [19]. Additional mechanisms include stabilization of nascent vasculature following stroke-induced angiogenesis and/or prevention of progressive neuronal cell loss via release of angiogenic and neurotrophic factors.
###end p 5
###begin p 6
###xml 183 187 183 187 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0009767-Connolly1">[20]</xref>
###xml 188 192 188 192 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0009767-Ferrara1">[22]</xref>
###xml 253 257 253 257 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0009767-Shweiki1">[23]</xref>
###xml 557 561 546 550 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0009767-Semenza1">[24]</xref>
###xml 673 677 662 666 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0009767-Arany1">[25]</xref>
###xml 695 699 684 688 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0009767-Mizukami1">[26]</xref>
###xml 701 705 690 694 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0009767-Birk1">[27]</xref>
###xml 719 723 708 712 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0009767-Hua1">[28]</xref>
###xml 752 756 741 745 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0009767-McColl1">[29]</xref>
###xml 863 867 852 856 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0009767-Jin3">[21]</xref>
###xml 995 999 984 988 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0009767-Sun1">[30]</xref>
###xml 1319 1323 1308 1312 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0009767-Wang1">[31]</xref>
###xml 1187 1202 <span type="species:ncbi:10090">Transgenic mice</span>
Vascular endothelial growth factor (VEGF) is the most well-studied angiogenic factor, but also has been shown to exert direct neurotrophic signaling and to promote adult neurogenesis [20]-[22]. The most potent inducer of VEGF gene expression is hypoxia [23]. VEGF is transcriptionally regulated by hypoxia inducible factor-1alpha (HIF-1alpha), which translocates to the nucleus following hypoxia-induced stabilization, dimerizes with HIF-1beta (ARNT), and activates the hypoxia response element (HRE) in the promoter region of the VEGF gene (for review see [24]). VEGF is also regulated by HIF-independent mechanisms including other transcription factors and co-activators [25] (for reviews see [26], [27]), micro-RNAs [28], and inflammatory mediators [29]. In neurons, VEGF mediates its neurotrophic effects via the receptor tyrosine kinase, VEGFR-2 (Flk-1/KDR) [21]. Following stroke, exogenous administration of VEGF has been shown to reduce infarct size and improve neurological performance [30]. These effects are thought to be due to both a direct neurotrophic action of VEGF on neurons and stimulation of angiogenesis for re-establishment of blood flow following ischemic damage. Transgenic mice with VEGF-overexpression also display increased neurogenesis, decreased infarct volume, and improved motor function [31].
###end p 6
###begin p 7
###xml 138 142 138 142 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0009767-Chu1">[32]</xref>
###xml 143 147 143 147 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0009767-Hayashi1">[34]</xref>
###xml 520 524 520 524 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0009767-Roitbak1">[35]</xref>
###xml 671 679 671 679 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 684 691 684 691 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
Neural stem cells have previously been shown to provide neuroprotection when transplanted into the adult brain in rodent models of stroke [32]-[34], raising the possibility that the endogenous SVZ response to stroke may also provide neuroprotection of penumbral neurons at risk of delayed cell death. We have previously demonstrated that embryonic neural stem cells secrete diffusible VEGF, which underlies their ability to protect endothelial cells against severe ischemia and promote angiogenesis in ischemic striatum [35]. In the present study, we investigated whether embryonic or postnatal NSPCs also provide neuroprotection against cerebral ischemia utilizing both in vitro and in vivo approaches. Here, we demonstrate that both embryonic and postnatal NSPCs are robustly resistant to oxygen-glucose deprivation (OGD), and provide neuroprotection under ischemic conditions, an effect that is mediated by HIF-1alpha-regulated release of diffusible VEGF by primary NSPCs. These studies have important implications for both the therapeutic use of exogenous NSPCs in stroke and also suggest a potential neuroprotective role for endogenous NSPCs in adult brain repair.
###end p 7
###begin title 8
Results
###end title 8
###begin title 9
###xml 53 60 53 60 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
NSPCs provide neuroprotection against focal ischemia in vivo
###end title 9
###begin p 10
###xml 336 340 333 337 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0009767-Roitbak1">[35]</xref>
###xml 746 755 743 752 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0009767-g001">Figure 1A</xref>
###xml 977 986 974 983 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0009767-g001">Figure 1B</xref>
###xml 1108 1119 1105 1116 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0009767-g001">Figure 1E,F</xref>
###xml 1156 1157 1153 1154 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 1258 1259 1255 1256 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 1267 1278 1264 1275 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0009767-g001">Figure 1C,D</xref>
###xml 1516 1520 1513 1517 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0009767-Roitbak1">[35]</xref>
###xml 1804 1813 1801 1810 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0009767.s001">Figure S1</xref>
###xml 1904 1912 1901 1909 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 1970 1974 1967 1971 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0009767-Plesnila1">[36]</xref>
###xml 21 26 <span type="species:ncbi:10090">mouse</span>
###xml 125 140 <span type="species:ncbi:10090">transgenic mice</span>
###xml 458 462 <span type="species:ncbi:10090">mice</span>
###xml 472 476 <span type="species:ncbi:10090">mice</span>
###xml 885 889 <span type="species:ncbi:10090">mice</span>
###xml 1220 1224 <span type="species:ncbi:10090">mice</span>
To determine whether mouse NSPCs are neuroprotective in our animal model of focal ischemia, we isolated embryonic NSPCs from transgenic mice that express enhanced green fluorescent protein (EGFP) under the beta-actin promoter. We have previously demonstrated that these NSPCs fulfill the criteria of multi-potentiality and self-renewal [35]. EGFP-NSPCs were expanded in culture and subsequently transplanted into the right dorsal striatum of adult recipient mice. Control mice received vehicle injections of phosphate buffered saline only. Seventy-two hours following transplantation, recipients were subjected to an ipsilateral transient middle cerebral artery occlusion (MCAO) for 30 minutes, followed by three days of reperfusion. As shown in Figure 1A, MCAO resulted in a robust apoptotic response at three days as assessed by TUNEL labeling of injured striatum in vehicle treated mice. EGFP-NSPC recipients displayed >50% fewer TUNEL+ nuclei compared to vehicle controls (Figure 1B), particularly in the area immediately surrounding the graft and extending out to at least 4.5 mm from the graft border (Figure 1E,F). Conversely, healthy appearing NeuN+ neuronal nuclei were numerous near the graft, whereas control mice displayed widespread loss of NeuN+ cells (Figure 1C,D). These data demonstrate robust NSPC-mediated neuroprotection against focal ischemia in the MCAO model. We previously reported that NSPC-transplant promotes vascularization and proliferation of blood vessels within the ischemic striatum [35], suggesting an effect of NSPCs on the vasculature. Activated neutrophils, as identified by myeloperoxidase (MPO) staining, were not observed in either vehicle- or NSPC-injected striatum, suggesting that NSPC transplantation does not alter the inflammatory response following stroke (Figure S1). To test whether NSPCs have a direct effect on neurons during ischemia, we shifted to an in vitro cell culture system using a well-characterized OGD model [36].
###end p 10
###begin title 11
NSPCs protect against 30 minute MCAO.
###end title 11
###begin p 12
###xml 1 4 1 4 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A&#8211;D</bold>
###xml 197 198 197 198 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 295 296 295 296 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">E</bold>
###xml 408 409 408 409 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">F</bold>
###xml 128 132 <span type="species:ncbi:10090">Mice</span>
###xml 511 515 <span type="species:ncbi:10090">mice</span>
(A-D) Coronal histological sections through the ischemic striatum 3 days following MCAO, stained for TUNEL (A,B) or NeuN (C,D). Mice received intrastriatal injections of exogenous PBS (A,C) or EGFP+NSPCs (B,D,E) 72 hr prior to MCAO. Inset in (B) shows 40x magnified view of the injection site. (E) Monochrome conversion of image shown in B to demonstrate concentric ring structures used for Sholl analysis. (F) Quantification of TUNEL+ cells using Sholl analysis performed on fluorescent images. *p<0.05, n = 5 mice per group. Scale bar: A,B  =  20 microm; C,D  =  10 microm.
###end p 12
###begin title 13
###xml 77 85 77 85 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
NSPCs provide neuroprotection against OGD and are intrinsically resistant to in vitro ischemia
###end title 13
###begin p 14
###xml 408 411 404 407 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">vs.</italic>
###xml 458 466 454 462 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0009767-g002">Figure 2</xref>
###xml 501 502 497 498 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 546 547 542 543 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 801 810 797 806 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0009767-g002">Figure 2B</xref>
###xml 920 924 916 920 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0009767-Wetzel1">[37]</xref>
###xml 1111 1120 1095 1104 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0009767-g002">Figure 2C</xref>
We utilized a transwell coculture paradigm to begin to delineate the mechanisms underlying NSPC-mediated neuroprotection. NSPCs and cortical neurons were cultured separately as monocultures or were cocultured in separate compartments of porous transwells (0.4 microm pore size), which allowed for sharing of conditioned media but did not allow cell-cell contact between NSPCs and neurons seeded in the upper vs. lower compartments, respectively. As shown in Figure 2, cortical cultures contained MAP-2+ neurons, with minimal contamination by GFAP+ astrocytes, and NSPC cultures were uniformly immunopositive for the stem cell marker, nestin. Neuronal and NSPC cultures were subjected to control or OGD conditions for 2 hours and assessed for cell viability 24 hr later using an MTT assay. As shown in Figure 2B, cortical cultures underwent approximately 40% cell loss within 24 hr following OGD, as previously described [37], but only approximately12% cell loss when cocultured with NSPCs. Importantly, NSPC monocultures were robustly resistant to 2 hour OGD and displayed no significant cell loss at 24 hours (Figure 2C). These data indicate that NSPCs provide robust neuroprotection of cortical neurons in culture via diffusible substance(s), and are themselves resistant to OGD conditions.
###end p 14
###begin title 15
###xml 63 71 63 71 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
NSPCs provide neuroprotection against OGD and are resistant to in vitro ischemia.
###end title 15
###begin p 16
###xml 1 2 1 2 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</bold>
###xml 260 261 260 261 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</bold>
###xml 375 376 375 376 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C</bold>
###xml 518 525 518 525 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="sec" rid="s4">methods</xref>
(A) Diagram of transwell coculture. Micrograph depicts cortical neurons in lower compartment immunofluorescently labeled for MAP-2 (red) and GFAP (green). NSPCs in upper compartment are immunofluorescent for nestin (red). Nuclei are labeled with DAPI (blue). (B) Neuronal survival at 24 hrs following 2 hr exposure to OGD in the absence (left) or presence (right) of NSPCs. (C) Survival of NSPCs grown as monocultures in upper compartment. Data were acquired using the MTT colorimetric viability assay as described in methods section. *p<0.01, Student's t-test, n = 4 cultures/group.
###end p 16
###begin title 17
Diffusible VEGF is responsible for NSPC-mediated neuroprotection against OGD
###end title 17
###begin p 18
###xml 248 257 244 253 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0009767-g003">Figure 3A</xref>
###xml 589 598 573 582 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0009767-g003">Figure 3B</xref>
HIF-1alpha is a key mediator of the adaptive cellular response to hypoxia and acts through transcriptional and non-transcriptional pathways to regulate the activities of genes involved in cell survival and angiogenesis, including VEGF. As shown in Figure 3A, NSPC monocultures constitutively expressed HIF-1alpha and displayed a nearly 3-fold increase in HIF-1alpha expression measured 24 hr following a 2 hr exposure to OGD. In contrast, HIF-1alpha was not measurable in neuronal monocultures under nonhypoxic conditions or at 24 hr following a 2 hr OGD exposure (not shown). As shown in Figure 3B, both neuronal and NSPC monocultures constitutively expressed the HIF-1alpha target gene, VEGF, and released VEGF into the culture media. VEGF release was not statistically different in cortical monocultures following OGD, but was increased 2.5-fold in NSPC monocultures as measured 24 hr following 2 hr exposure to OGD. Culture media from NSPCs was also used to measure the presence of brain-derived neurotrophic factor (BDNF), however BDNF was undetected in both control and OGD-exposed NSPC media (data not shown).
###end p 18
###begin title 19
###xml 63 66 59 62 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">vs.</italic>
HIF-1alpha and VEGF expression in eNSPC cultures under control vs. OGD conditions.
###end title 19
###begin p 20
###xml 1 2 1 2 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</bold>
###xml 125 126 121 122 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</bold>
(A) HIF-1alpha protein levels in cell lysates from eNSPCs at 24 hrs following a 2 hr exposure to OGD or control conditions. (B) VEGF within neuronal or NSPC conditioned media following 2 hr exposure to control or OGD conditions. Media was conditioned for 24 hrs following exposure to OGD or control conditions. *p<0.05, Student's t-test, n = 4 cultures/group.
###end p 20
###begin p 21
###xml 245 254 241 250 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0009767-g004">Figure 4A</xref>
###xml 309 318 301 310 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0009767-g004">Figure 4B</xref>
###xml 399 408 391 400 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0009767-g004">Figure 4A</xref>
###xml 718 727 710 719 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0009767-g004">Figure 4B</xref>
###xml 892 901 884 893 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0009767.s002">Figure S2</xref>
###xml 1098 1107 1090 1099 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0009767-g004">Figure 4C</xref>
###xml 1218 1227 1210 1219 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0009767.s003">Figure S3</xref>
To determine whether diffusible VEGF is responsible for NSPC-mediated neuroprotection, neurons in monoculture or in transwell coculture with NSPCs were exposed to OGD in the presence or absence of the VEGFR2 kinase inhibitor, SU1498 (10 microM; Figure 4A) or the VEGF decoy receptor, Flt-1-Fc (1.0 microg/ml; Figure 4B) added at the onset of OGD and present for 24 hr thereafter. As demonstrated in Figure 4A, SU1498 had no effect on neuronal viability under non-ischemic conditions, but completely inhibited the ability of NSPCs to provide neuroprotection against OGD in coculture. Prevention of VEGF-VEGFR interaction at the cell surface with Flt-1-Fc also impaired the neuroprotection provided by cocultured NSPCs (Figure 4B). Dose-response analysis for both SU1498 and Flt-1-Fc showed that neither compound was cytotoxic to neurons in monoculture at the concentration used in this study (Figure S2). Exposure of neuronal cultures to NSPC-conditioned media resulted in significant neuroprotection against OGD, an effect that was also blocked by SU1498 and Flt-1-Fc inhibition of VEGF signaling (Figure 4C). Flt-1-Fc was not cytotoxic to NSPCs, and had no effect on the ability of NSPCs to withstand OGD conditions (Figure S3). These data indicate that NSPC-mediated neuroprotection is mediated by diffusible VEGF and dependent on neuronal VEGFR signaling.
###end p 21
###begin title 22
Pharmacological inhibition of VEGF signaling impairs the neuroprotective effects of eNSPCs.
###end title 22
###begin p 23
###xml 1 4 1 4 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A,B</bold>
###xml 217 218 217 218 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C</bold>
(A,B) Neuronal viability 24 hrs following exposure to 2 hr OGD vs. control conditions in the presence or absence of NSPCs and the VEGFR kinase inhibitor, SU1498 (A) or the VEGF receptor decoy receptor, Flt-1-Fc (B). (C) Neuronal viability in the presence or absence of NSPC-conditioned media and SU1498 or Flt-1Fc. *p<0.05, n = 4 cultures/group.
###end p 23
###begin title 24
Gene deletion of HIF-1alpha impairs NSPC-mediated neuroprotection
###end title 24
###begin p 25
###xml 250 255 238 243 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">fl/fl</sup>
###xml 257 261 245 249 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0009767-Ryan1">[38]</xref>
###xml 273 278 257 262 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">wt/wt</sup>
###xml 293 298 273 278 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">fl/fl</sup>
###xml 457 466 437 446 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0009767-g005">Figure 5A</xref>
###xml 569 574 541 546 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">fl/fl</sup>
###xml 592 603 560 563 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#916;/&#916;</sup>
###xml 627 632 583 588 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">wt/wt</sup>
###xml 906 917 854 857 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#916;/&#916;</sup>
###xml 946 951 882 887 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">wt/wt</sup>
###xml 959 968 895 904 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0009767-g005">Figure 5B</xref>
###xml 1067 1078 995 998 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#916;/&#916;</sup>
###xml 1107 1112 1023 1028 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">wt/wt</sup>
###xml 1142 1151 1058 1067 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0009767-g005">Figure 5C</xref>
###xml 1254 1257 1164 1167 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">vs.</italic>
###xml 1285 1290 1189 1194 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">wt/wt</sup>
###xml 1290 1293 1194 1197 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">vs.</italic>
###xml 1304 1315 1204 1207 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#916;/&#916;</sup>
###xml 1342 1351 1234 1243 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0009767.s004">Figure S4</xref>
###xml 1423 1432 1315 1324 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0009767-g005">Figure 5D</xref>
###xml 1537 1548 1421 1424 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#916;/&#916;</sup>
###xml 145 160 <span type="species:ncbi:10090">transgenic mice</span>
###xml 435 438 <span type="species:ncbi:12305?0.03296277145811789|species:ncbi:36410?3.8779731127197516E-4">CMV</span>
###xml 506 509 <span type="species:ncbi:12305?0.03296277145811789|species:ncbi:36410?3.8779731127197516E-4">CMV</span>
###xml 723 726 <span type="species:ncbi:12305?0.03296277145811789|species:ncbi:36410?3.8779731127197516E-4">CMV</span>
To determine the extent to which endogenous NSPC HIF-1alpha governs VEGF expression and NSPC-mediated neuroprotection, eNSPCs were isolated from transgenic mice that harbor loxP sites flanking exon 2 of the HIF-1alpha gene at both alleles (HIF-1alphafl/fl) [38]. HIF-1alphawt/wt and HIF-1alphafl/fl NSPC cultures were incubated for 24 hr with adenovirus harboring a bacterial Cre-recombinase gene sequence to confer Cre expression (Ad-CMV-Cre). As shown in Figure 5A, transduction of NSPC cultures with Ad-CMV-Cre resulted in excision of HIF-1alpha exon 2 in HIF-1alphafl/fl NSPCs (HIF-1alphaDelta/Delta), but not in HIF-1alphawt/wt NSPCs, as indicated by PCR analysis of genomic DNA isolated 24 hr following removal of Ad-CMV-Cre. HIF-1alpha transcriptional activity was completely abolished as assessed by the inability of nuclear extract proteins to bind the hypoxia response element (HRE) in HIF-1alphaDelta/Delta cells, but not in HIF-1alphawt/wt cells (Figure 5B). HIF-1alpha gene deletion in NSPCs also resulted in a 50% reduction of VEGF release by HIF-1alphaDelta/Delta NSPCs compared to HIF-1alphawt/wt NSPCs in response to anoxia (Figure 5C). HIF-1alpha gene deletion had no effect on NSPC survival at 24 hr following 2 hr OGD (96.8 %+/-8.5 % vs. 101.6 %+/-6.7 %, HIF-1alphawt/wtvs. HIF-1alphaDelta/Delta, respectively, ns, n = 4; Figure S4), but abrogated the neuroprotective effects of NSPC conditioned media (Figure 5D). Thus, HIF-1alpha appears to be necessary for NSPC-mediated neuroprotection since media from HIF-1alphaDelta/Delta cultures failed to protect neurons from OGD-induced death.
###end p 25
###begin title 26
Gene deletion of HIF-1alpha impairs neuroprotective ability of eNSPC.
###end title 26
###begin p 27
###xml 1 2 1 2 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</bold>
###xml 86 91 82 87 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">fl/fl</sup>
###xml 271 276 259 264 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">fl/fl</sup>
###xml 303 304 291 292 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</bold>
###xml 372 383 352 355 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#916;/&#916;</sup>
###xml 421 422 393 394 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C</bold>
###xml 485 496 453 456 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#916;/&#916;</sup>
###xml 505 506 465 466 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">D</bold>
###xml 604 607 564 567 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">vs.</italic>
###xml 618 629 574 577 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#916;/&#916;</sup>
###xml 119 122 <span type="species:ncbi:12305?0.03296277145811789|species:ncbi:36410?3.8779731127197516E-4">CMV</span>
###xml 240 243 <span type="species:ncbi:12305?0.03296277145811789|species:ncbi:36410?3.8779731127197516E-4">CMV</span>
(A) PCR amplification products from genomic DNA isolated from wild-type and HIF-1alphafl/fl NSPCs exposed to 50 MOI Ad-CMV-Cre for 48 hrs. Excision of exon 2 from HIF-1alpha gene is indicated by the shorter band at 250 bp, present after Ad-CMV-Cre exposure of HIF-1alpha fl/fl but not wild-type NSPCs. (B) Transcriptional activity of HIF-1alpha in wild-type vs. HIF-1alphaDelta/Delta NSPCs assayed by HRE binding assay. (C) VEGF in 24 hr conditioned media from wild-type vs. HIF-1alphaDelta/Delta NSPCs. (D) Viability of cortical cultures 24 hr following 2 hr OGD in the presence or absence of wild-type vs. HIF-1alphaDelta/Delta NSPCs CM. *p<0.05, n =  4 cultures/group.
###end p 27
###begin title 28
Postnatal NSPCs are neuroprotective, resistant to ischemia and constitutively express stabilized HIF-1alpha and VEGF
###end title 28
###begin p 29
###xml 87 95 87 95 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 242 250 242 250 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0009767-g006">Figure 6</xref>
###xml 507 516 503 512 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0009767-g006">Figure 6C</xref>
###xml 594 603 590 599 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0009767-g006">Figure 6D</xref>
###xml 146 151 <span type="species:ncbi:10090">mouse</span>
To determine whether postnatal NSPCs also confer neuroprotection and are resistance to in vitro ischemia, we isolated NSPCs from postnatal day 28 mouse SVZ and expanded the pNSPCs in culture using the same paradigm as for eNSPCs. As shown in Figure 6 (A and B), pNSPCs constitutively expressed stabilized HIF-1alpha and VEGF at levels similar to eNSPCs under non-ischemic conditions, with robust induction of both proteins in response to 24 hr anoxia. pNSPCs also displayed resistance to 2 hr OGD exposure (Figure 6C), and media conditioned by pNSPCs provided neuroprotection against 2 hr OGD (Figure 6D).
###end p 29
###begin title 30
Postnatal NSPCs are neuroprotective and resistant to ischemia.
###end title 30
###begin p 31
###xml 1 2 1 2 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</bold>
###xml 51 52 47 48 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</bold>
###xml 171 172 167 168 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C</bold>
###xml 214 215 210 211 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">D</bold>
###xml 310 313 306 309 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">vs.</italic>
(A) HIF-1alpha protein levels in cell lysates and (B) VEGF concentration in conditioned medium from pNSPCs at 24 hr following 2 hr exposure to control or OGD conditions. (C) Viability of pNSPCs at 24 hr post-OGD. (D) Viability of cortical neuronal cultures 24 hr following 2 hr OGD in the presence of neuronal vs. pNSPC conditioned medium. *p<0.05, n = 4 cultures/group.
###end p 31
###begin title 32
Discussion
###end title 32
###begin p 33
###xml 283 290 279 286 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
In this study, we investigated the neuroprotective effects of embryonic and postnatal NSPCs under conditions of ischemia, and the role of HIF-1alpha-regulated VEGF signaling in this process. We found that exogenous NSPCs protect neurons against focal ischemic injury induced by MCAO in vivo, and protect embryonic cortical neurons against OGD exposure in culture. In contrast to primary cortical neurons, NSPCs display intrinsic resistance to brief 2 hr OGD exposure in culture, and constitutively express stabilized HIF-1alpha and its downstream target, VEGF. Pharmacological blockade of VEGF signaling in culture impairs neuroprotection, and HIF-1alpha gene deletion in NSPCs results in both impaired VEGF production and impaired neuroprotection against OGD. These observations provide evidence that NSPCs promote neuronal survival under conditions of ischemia via HIF-1alpha-regulated VEGF signaling and suggest that NSPCs may play a neuroprotective role following stroke.
###end p 33
###begin p 34
###xml 287 291 287 291 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0009767-Kovacs1">[39]</xref>
###xml 292 296 292 296 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0009767-Marti1">[41]</xref>
###xml 447 451 447 451 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0009767-Sun1">[30]</xref>
###xml 453 457 453 457 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0009767-Greenberg1">[42]</xref>
###xml 459 463 459 463 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0009767-Zhang3">[43]</xref>
###xml 477 481 477 481 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0009767-Greenberg1">[42]</xref>
###xml 483 487 483 487 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0009767-Hansen1">[44]</xref>
###xml 489 493 489 493 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0009767-Carmeliet1">[45]</xref>
###xml 553 561 553 561 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 718 722 718 722 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0009767-Taoufik1">[46]</xref>
###xml 723 727 723 727 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0009767-Jin6">[51]</xref>
###xml 786 794 786 794 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 1072 1076 1072 1076 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0009767-Roitbak1">[35]</xref>
VEGF is recognized as both a vasculotrophic factor and a neurotrophic factor. VEGF expression in the brain is downregulated in early postnatal life after formation of the cerebral vasculature is complete, but becomes upregulated in adult brain in response to stroke or mechanical injury [39]-[41]. Administration of exogenous VEGF following stroke results in reduced neuronal cell death, increased angiogenesis and increased vascular permeability [30], [42], [43] (reviewed in [42], [44], [45]). VEGF also exerts a direct neuroprotective effect against in vitro ischemia, mediated by neuronal VEGFR2 signaling and downstream activation of the phosphatidylinositol 3-kinase (PI3 kinase)/Akt pathway in cultured neurons [46]-[51]. Our studies suggest that VEGF release by NSPCs underlies in vitro neuroprotection against ischemia, via direct activation of neuronal VEGFR2 receptors, since neuroprotection was abrogated by the presence of the VEGFR2 kinase inhibitor, SU1498, and by the presence of the VEGFR decoy receptor, Flt-1-Fc. In conjunction with our previous report [35], VEGF could have a dual effect in the graft: improved revascularization and direct neuroprotection.
###end p 34
###begin p 35
###xml 90 94 90 94 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0009767-Roitbak1">[35]</xref>
###xml 96 100 96 100 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0009767-Teng1">[52]</xref>
###xml 101 105 101 105 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0009767-Madhavan1">[54]</xref>
###xml 202 206 202 206 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0009767-Roitbak1">[35]</xref>
###xml 208 212 208 212 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0009767-Madhavan1">[54]</xref>
###xml 824 832 824 832 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
VEGF production by both embryonic and adult NSPCs in culture has previously been reported [35], [52]-[54]. NSPC expression of VEGF is known to be upregulated in response to hypoxic and metabolic stress [35], [54]. Our present study demonstrates that cortical cultures also release diffusible VEGF under normoxic conditions but do not display increased VEGF production at 24 hr following 2 hr OGD, whereas VEGF release by NSPCs is increased 2-3 fold within 24 hr post-OGD. Although inhibition of VEGFR2 signaling blocks NSPC-mediated neuroprotection, inhibition of VEGFR2 signaling has no impact on the survival of neurons under normoxic conditions, and has no effect on the ability of NSPCs to survive ischemic insult. These observations suggest that increased VEGF production by NSPCs underlies neuronal protection against in vitro ischemia, but does not mediate NSPC resistance to ischemic conditions and is not required for survival of cortical neurons under normoxic conditions.
###end p 35
###begin p 36
###xml 175 176 167 168 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 811 815 788 792 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0009767-Semenza1">[24]</xref>
###xml 817 821 794 798 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0009767-Weidemann1">[55]</xref>
###xml 917 918 890 891 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 1172 1173 1137 1138 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 1293 1297 1250 1254 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0009767-Isaacs1">[56]</xref>
###xml 1416 1420 1369 1373 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0009767-Xiong1">[57]</xref>
One of the most potent regulators of VEGF expression is HIF-1alpha. HIF-1alpha is primarily regulated at the post-translational level, with protein stability dependent upon pO2. In most mammalian cell types, HIF-1alpha protein is hydroxylated under normoxic conditions, binds the von Hippel-Lindau (VHL) protein, and is rapidly degraded by the 26S proteosome. Under conditions of hypoxia, HIF-1alpha is not hydroxylated and rapidly accumulates to enter the nucleus and dimerize with HIF-1beta (ARNT), forming the HIF-1 transcriptional complex that regulates target genes through cis-acting hypoxia response elements (HREs). In most cell types HIF-1alpha mRNA is constitutively transcribed and translated, but the protein only has a half-life of less than 5 minutes under non-hypoxic conditions (for review, see [24], [55]). Our observation that HIF-1alpha is constitutively stabilized by cultured NSPCs, even at 21% O2, suggests that NSPCs may also utilize a non-oxygen dependent mechanism for maintaining HIF-1alpha stability and that HIF-1alpha plays a fundamental role in NSPC homeostasis under both normoxic and hypoxic conditions. Previous studies have demonstrated O2-independent stabilization of HIF-1alpha by heat shock protein 90 (HSP-90) through binding the PAS domain of HIF-1alpha [56]. HSP-90 has also been shown to be involved in the regulation of HIF-1alpha stability in embryonic mesencephalic NSPCs [57].
###end p 36
###begin p 37
###xml 385 389 377 381 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0009767-Bernaudin1">[58]</xref>
###xml 390 394 382 386 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0009767-Gustafsson1">[61]</xref>
###xml 507 515 495 503 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 546 550 534 538 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0009767-Theus1">[62]</xref>
###xml 604 608 592 596 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0009767-Chu1">[32]</xref>
###xml 774 778 758 762 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0009767-Bernaudin1">[58]</xref>
###xml 780 784 764 768 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0009767-Chen2">[63]</xref>
###xml 785 789 769 773 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0009767-Tsai1">[65]</xref>
###xml 986 990 970 974 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0009767-Tsai1">[65]</xref>
###xml 1031 1038 1015 1022 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 1108 1112 1092 1096 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0009767-Yang1">[66]</xref>
While the role of constitutive HIF-1alpha stabilization in NSPCs is not completely understood, HIF-1alpha is recognized as a multifunctional protein that regulates the expression and activity of multiple genes involved in angiogenesis, glucose metabolism, proliferation and self-renewal, apoptosis, and migration through both transcriptional and non-transcriptional signaling pathways [58]-[61]. Others have shown that upregulation of HIF-1alpha in neural progenitor cells enhances their ability to survive in vitro and following transplantation [62], as well as provide neuroprotection against ischemia [32]. In addition to VEGF, HIF-1alpha is a potent inducer of erythropoietin (EPO), which promotes neurogenesis, NSPC proliferation and neuroprotection following ischemia [58], [63]-[65]. However, neural-specific EPOR knockdown does not increase infarct volume following focal cerebral ischemia and therefore endogenous levels of EPO may not provide neuroprotection following stroke [65]. Conversely, antisense blockade of VEGF in vivo results in an enlargement of infarct volume caused by transient MCAO [66]. In the present study, we found that HIF-1alpha gene deletion results in >50% reduction of VEGF production and a concomitant impairment of neuroprotective activity in NSPC-conditioned medium. However, these data also indicate that VEGF production is at least partially regulated by HIF-1alpha-independent mechanisms in NSPCs, since HIF-1alpha gene deletion did not completely block VEGF production.
###end p 37
###begin p 38
###xml 212 216 208 212 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0009767-Roitbak1">[35]</xref>
###xml 862 866 858 862 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0009767-Maysami1">[15]</xref>
###xml 1123 1130 1115 1122 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 1215 1223 1207 1215 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 1333 1340 1325 1332 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
We previously demonstrated that embryonic NSPCs protect endothelial cells against ischemia-induced damage and stimulate increased endothelial cell proliferation via HIF-1alpha-regulated VEGF signaling mechanisms [35]. Here, we extend those studies to demonstrate that NSPCs also provide neuroprotection through similar signaling mechanisms. While neural stem cells were initially recognized as potential therapeutic agents for stroke and neurodegenerative disease based on their potential to replace lost neurons and integrate into host circuitry, our studies support the possibility that the therapeutic potential of neural stem cells may lie predominantly in their ability to promote endogenous brain repair processes. Following stroke, NSPCs and their progeny migrate to the lesioned area and inhibition of this migration leads to an increase in infarct size [15]. Our study reveals that NSPCs may directly protect against ischemic injury through the release of diffusible VEGF. Further studies will require NSPC-targeted gene deletion of VEGF and HIF-1alpha to delineate the role of endogenous NSPCs in neuroprotection in vivo, as well as their effects on other cell types within the neurovascular niche. While in vitro modeling is crucial to understanding the molecular mechanisms of the interactions between neurons and NSPCs, in vivo studies will account for the ischemic microenvironment.
###end p 38
###begin p 39
###xml 353 357 353 357 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0009767-Seminatore1">[67]</xref>
###xml 526 530 526 530 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0009767-Zhang3">[43]</xref>
###xml 424 429 <span type="species:ncbi:9606">human</span>
While our studies suggest that NSPCs themselves are neuroprotective and important for vascular remodeling following stroke, care must be taken with development of therapeutical strategies. Direct NSPC transplantation into the post-ischemic environment may lead to graft overgrowth and tumor formation due to their pluripotency and ability to self-renew [67]. While VEGF infusion may look promising, injection of recombinant human VEGF has been shown to promote blood vessel permeability as well as blood-brain barrier leakage [43]. Thus, elucidating the mechanisms by which NSPCs protect the ischemic penumbra following stroke will provide novel therapeutic strategies for facilitating the contribution of endogenous NSPCs for brain repair.
###end p 39
###begin title 40
Methods
###end title 40
###begin title 41
Primary cortical neuronal and neural stem/progenitor cultures
###end title 41
###begin p 42
###xml 502 506 502 506 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0009767-Wetzel1">[37]</xref>
###xml 539 540 539 540 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">5</sup>
###xml 698 699 698 699 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">6</sup>
###xml 1015 1020 1015 1016 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#181;</italic>
###xml 1075 1080 1071 1072 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#181;</italic>
###xml 1115 1123 1107 1115 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 1470 1474 1462 1466 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0009767-Ray1">[68]</xref>
###xml 2116 2121 2104 2105 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#181;</italic>
###xml 2298 2299 2276 2277 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 2376 2381 2354 2355 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#181;</italic>
###xml 194 198 <span type="species:ncbi:10090">mice</span>
###xml 1558 1562 <span type="species:ncbi:10090">mice</span>
Ethics Statement: This study was approved by the University of New Mexico Animal Care and Use Committee and conformed to the NIH Guidelines for use of animals in research. Timed pregnant female mice were sacrificed by isoflurane overdose and the embryos removed by cesarean section. Primary neuronal cultures were established from cerebral cortices of C57BL/6J embryos (The Jackson Laboratory, Bar Harbor, ME, USA) at gestation day 15, using enzymatic dissociation with trypsin as previously described [37]. For immunocytochemistry, 3.9x105 dissociated cells were plated on poly-L-lysine-coated coverslips (0.1 mg/ml; Sigma, St Louis, MO, USA) in 24-well plates. For biochemical procedures, 1.95x106 cells were plated on precoated poly-L-lysine six-well plates (BD Biosciences, San Diego, CA, USA). The cultures were maintained under serum-free conditions in neurobasal medium (Invitrogen Corp., Carlsbad, CA, USA), supplemented with B-27 supplement (2%; Invitrogen Corp.), glutamine (0.5 mM; Sigma), glutamate (25 microM; Sigma), penicillin (100 U/ml) and streptomycin (100 microg/ml; Invitrogen Corp.). At 4 days in vitro (DIV), half of the medium was removed and replaced with fresh medium without glutamate, as indicated by the manufacturer. At 7 DIV, neuronal cultures were used for experimentation. Embryonic neural stem/progenitor cells (eNSPC) were established from whole telencephalon of EGFP-C57BL/6J embryos at gestation day 14 (E14), as described previously [68]. Postnatal NSPCs (pNSPC) were established from postnatal day 28 male EGFP-C57BL/6J mice. NSPCs were plated on pre-coated poly-L-lysine six-well plates (BD Biosciences). Growth factors were added every other day and cells were passaged at least twice prior to use. NSPCs used for coculture were plated on 0.4 microM pore size transwells (BD Biosciences) coated with poly-L-lysine (0.1 mg/mL; Sigma). The cultures were maintained under serum-free conditions in neurobasal medium (Invitrogen Corp.), supplemented with B-27 supplement (2%; Invitrogen Corp.), glutamine (2.0 mM; Sigma), penicillin (100 U/ml; Invitrogen Corp.), streptomycin (100 microg/ml; Invitrogen Corp.), EGF (10 ng/mL; Invitrogen Corp.), and bFGF (10 ng/mL; Invitrogen Corp.). All cultures were maintained in a humidified incubator at 37degreesC with 5% CO2. The cultures were incubated with the following compounds: SU1498 (70 nM-50 microM; Calbiochem, San Diego, CA, USA), IgG-Fc (5 ng/mL-1 microg/mL; Jackson ImmunoResearch Laboratories, West Grove, PA, USA), and Flt-1-Fc (5 ng/mL-1 microg/mL; R&D Systems, Minneapolis, MN, USA).
###end p 42
###begin title 43
Oxygen-glucose deprivation
###end title 43
###begin p 44
###xml 71 75 71 75 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0009767-Plesnila1">[36]</xref>
###xml 77 81 77 81 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0009767-Wetzel1">[37]</xref>
###xml 240 241 240 241 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 247 248 247 248 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 258 259 258 259 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 268 269 268 269 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 640 645 634 635 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#181;</italic>
###xml 816 817 800 801 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 979 984 963 964 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#181;</italic>
Oxygen-glucose deprivation (OGD) was performed as previously described [36], [37]. Primary cortical neuronal cultures and/or NSPCs were placed in an anaerobic chamber (Coy Laboratories, Grass Lake, MI, USA) containing a gas mixture of 5% CO2, 5% H2 and 85% N2 (<0.2% O2). Normal culture media was replaced with deoxygenated, glucose-free Earle's balanced salt solution, and the cultures were maintained under glucose-free anaerobic conditions at 37degreesC for 2 h. OGD was terminated by returning the cultures to normoxic conditions and neurobasal medium supplemented with 2% B-27 supplement, 0.5 mM glutamine, 100 U/ml penicillin and 100 microg/ml streptomycin. As a control, sister cultures were placed in Earle's balanced salt solution containing 25 mM glucose (Sigma) for 2 h at 37degreesC under normoxic (21% O2) conditions and then returned under normoxic conditions to neurobasal medium supplemented with 2% B-27 supplement, 0.5 mM glutamine, 100 U/ml penicillin and 100 microg/ml streptomycin.
###end p 44
###begin title 45
Mild transient middle cerebral artery occlusion (MCAO)
###end title 45
###begin p 46
###xml 136 146 136 146 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ad libitum</italic>
###xml 403 407 397 401 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0009767-Kokovay1">[69]</xref>
###xml 20 24 <span type="species:ncbi:10090">mice</span>
###xml 148 152 <span type="species:ncbi:10090">Mice</span>
###xml 327 331 <span type="species:ncbi:10090">Mice</span>
###xml 1014 1018 <span type="species:ncbi:10090">mice</span>
Adult male C57BL/6J mice 20-25 g (The Jackson Laboratory) were housed under a 12 h light: 12 h dark cycle with food and water available ad libitum. Mice (20-25 g; n = 20) were anesthetized with 4% isoflurane for induction and maintained on 1.0% isoflurane. The body temperature was maintained at 37degreesC with a heating pad. Mice were subjected to 30 minutes of transient MCAO as previously described [69]. Briefly, the right common carotid artery was exposed through a midline incision. The internal carotid artery was isolated from external carotid artery which was ligated with 6-0 silk suture. A 2-cm length of 6-0 rounded tip nylon suture was advanced from the common carotid artery (CCA), through the internal carotid artery up to the level of the anterior cerebral artery. The suture was inserted 10 to 11 mm from the bifurcation of CCA to occlude the middle cerebral artery (MCA). After 30 min of MCAO, the suture was slowly withdrawn to allow for reperfusion. Reperfusion time was 3 days post-MCAO. The mice were anesthetized with sodium pentobarbital (150 mg/kg, Fort Dodge Animal Health, Fort Dodge, IA, USA) administered intraperitoneally, and were transcardially perfused first with preperfusing solution (0.01 mg/ml heparin and 1 mg/ml procaine) and subsequently with 4% paraformaldehyde in 0.1 M phosphate buffered saline (PBS). The brains were removed, post-fixed overnight in 4% paraformaldehyde, and cryoprotected with 30% sucrose (w/v) in 0.1 M PBS for 48 hours at 4degreesC. For immunohistochemical procedures (described below), the brains were sectioned at 30 microm using a sliding microtome (AO Scientific Instruments, Buffalo, NY, USA).
###end p 46
###begin title 47
Embryonic NSPC Transplantation
###end title 47
###begin p 48
###xml 427 428 419 420 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">4</sup>
###xml 60 65 <span type="species:ncbi:10090">mouse</span>
###xml 160 165 <span type="species:ncbi:10090">mouse</span>
###xml 176 180 <span type="species:ncbi:10090">Mice</span>
NSPCs isolated from E14 EGFP-expressing transgenic C57BL/6J mouse embryos were expanded in culture as described above and transplanted into 8 week-old C57BL/6J mouse striatum. Mice were anaesthetized with 2% isoflurane inhalation. Stereotaxic injections were performed using Hamilton microsyringe with a 26-gauge blunt needle. Each animal received an injection of 2.5 microl (at the rate of 1 microl/min, and concentration 5x104 cells/microl) of EGFP-NSPCs into the striatum (from bregma: A +1.0 mm, L +2.0 mm, V -2.6 mm). To identify fragmentation of DNA characteristic of apoptosis, TUNEL labeling was performed on paraformaldehyde fixed tissue from 30 minutes MCAO using NeurotacsTM II kit (Trevigen, Inc, Gaithersburg, MD, USA), according to the manufacturer's protocol. Tissue treated with TACs-nucleasetrade mark or without terminal deoxynucleotidyl transferase served as positive and negative controls, respectively. NIH ImageJ software was used to quantify TUNEL+ cells from fluorescent images using Sholl analysis, with concentric rings placed at increasing distances (635 microm apart) around the perimeter of the graft.
###end p 48
###begin title 49
Immunohistochemistry
###end title 49
###begin p 50
###xml 93 98 <span type="species:ncbi:10090">mouse</span>
###xml 160 166 <span type="species:ncbi:9986">rabbit</span>
###xml 215 221 <span type="species:ncbi:9986">rabbit</span>
###xml 333 338 <span type="species:ncbi:10090">mouse</span>
###xml 382 388 <span type="species:ncbi:9986">rabbit</span>
Cultured cells were fixed on coverslips with 4% paraformaldehyde and incubated in monoclonal mouse anti-Nestin (1:500; Chemicon, Temecula, CA, USA), polyclonal rabbit anti-MAP-2 (1:500; Chemicon), and/or polyclonal rabbit anti-GFAP (1:500; Accurate, Westbury, NY, USA). Histological sections (30 microm) were incubated in monoclonal mouse anti-NeuN (1:1000, Chemicon) or polyclonal rabbit anti-MPO (1:500, Santa Cruz Biotechnology, Santa Cruz, CA, USA). Immunofluorescence was visualized using FITC- or Cy3-conjugated secondary antibodies (1:250; Jackson ImmunoResearch Laboratories). DAPI nuclear stain was used to identify cell bodies of cultured cells (Invitrogen Corp.). Immunofluorescence was analyzed using high-resolution confocal microscopy (Zeiss LSM510, Thornwood, NY, USA) or conventional fluorescence microscopy.
###end p 50
###begin title 51
Immunoassays
###end title 51
###begin p 52
###xml 78 83 <span type="species:ncbi:10090">Mouse</span>
###xml 207 212 <span type="species:ncbi:9606">Human</span>
###xml 213 218 <span type="species:ncbi:10090">Mouse</span>
###xml 455 460 <span type="species:ncbi:10090">mouse</span>
Soluble VEGF or BDNF were assayed from conditioned media using the Quantikine Mouse Immunoassay for the appropriate protein (R&D Systems). HIF-1alpha was measured in cell lysates using Surveyortrade mark IC Human/Mouse Total HIF-1alpha Immunoassay (R&D Systems). Transcriptional activity of HIF-1alpha was measured in nuclear extract using the TransAM HIF-1 kit (Active Motif, Carlsbad, CA, USA), substituting the primary antibody for one that recognizes mouse (Novus Biologicals, Littleton, CO, USA). Nuclear extracts used in this assay were isolated using the NE-PER Nuclear and Cytoplasmic Extraction Reagent Kit (Pierce, Rockford, IL, USA). Absorbance for all assays was read using a microplate reader (Dynex Technologies, Chantilly, VA, USA): Quantikine assays were read at 450 nm with background subtraction of 570 nm; TransAM assay was read at 450 nm with a background subtraction of 630 nm.
###end p 52
###begin title 53
MTT cell viability assay
###end title 53
###begin p 54
Cell viability was assessed using methylthiazolyldiphenyl-tetrazolium bromide (MTT) dissolved in PBS (0.5 mg/mL; Sigma). Cultures were incubated with MTT at 37degreesC for 4 hr. Formazan crystals were solubilized using 1:1 ethanol:DMSO solution. Absorbance was measured at 570 nm with a background subtraction of 630 nm.
###end p 54
###begin title 55
HIF-1alpha gene deletion from NSPCs
###end title 55
###begin p 56
###xml 123 128 115 120 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">fl/fl</sup>
###xml 130 134 122 126 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0009767-Ryan1">[38]</xref>
###xml 732 766 720 754 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242;- TGT TAA ATA AAA GCT TGG AC -3&#8242;</named-content>
###xml 786 820 774 808 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242;- GCA GTT AAG AGC ACT AGT TG -3&#8242;</named-content>
###xml 820 824 808 812 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0009767-Milosevic1">[70]</xref>
###xml 903 914 883 886 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#916;/&#916;</sup>
###xml 1045 1056 1013 1016 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#916;/&#916;</sup>
###xml 42 57 <span type="species:ncbi:10090">transgenic mice</span>
###xml 307 310 <span type="species:ncbi:12305?0.03296277145811789|species:ncbi:36410?3.8779731127197516E-4">CMV</span>
###xml 1133 1136 <span type="species:ncbi:12305?0.03296277145811789|species:ncbi:36410?3.8779731127197516E-4">CMV</span>
NSPCs were isolated from embryonic day 14 transgenic mice containing loxP-flanked exon 2 of the HIF-1alpha gene (HIF-1alphafl/fl) [38] that were crossed to the C57BL/6J background (The Jackson Laboratory). NSPCs were passaged twice prior to 48 hr treatment with an adenovirus expressing Cre-recombinase (Ad-CMV-Cre; Vector Biolabs, Philadelphia, PA, USA) at 50 MOI (multiplicity of infection). This method recombines the DNA between the two loxP sites to excise the intervening sequence. Twenty-four hours after infection, NSPCs were passaged twice more before used in experiments. To confirm deletion of exon 2 of the HIF-1alpha gene, DNA was isolated and efficiency of cre-recombination was detected with PCR using forward primer 5'- TGT TAA ATA AAA GCT TGG AC -3' and reverse primer 5'- GCA GTT AAG AGC ACT AGT TG -3'[70]. Successful DNA recombination yields HIF-1alpha gene-deleted NSPCs (HIF-1alphaDelta/Delta), as indicated by the loss of the 1200 bp band amplification product and appearance of a 250 bp band. Experiments using HIF-1alphaDelta/Delta eNSPCs were compared to wild-type C57BL/6J eNSPCs treated similarly with Ad-CMV-Cre.
###end p 56
###begin title 57
Statistical Analysis
###end title 57
###begin p 58
###xml 177 185 175 183 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">post hoc</italic>
Data are expressed as means +/- S.E.M. Significant differences between means were determined by student's t-test or analysis of variance (ANOVA) with Tukey multiple comparisons post hoc analysis using Prism software (Graphpad Software, San Diego, CA, USA). P values < 0.05 are considered statistically significant.
###end p 58
###begin title 59
Supporting Information
###end title 59
###begin p 60
###xml 181 185 <span type="species:ncbi:10090">Mice</span>
Myeloperoxidase (MPO) staining for activated neutrophils. (A-D) Myeloperoxidase (MPO) staining of coronal histological sections through the ischemic striatum 3 days following MCAO. Mice received intrastriatal injections of exogenous EGFP+NSPCs (A-C) or PBS (D) 72 hr prior to MCAO. Scale bar: 10 microm.
###end p 60
###begin p 61
(4.33 MB TIF)
###end p 61
###begin p 62
Click here for additional data file.
###end p 62
###begin p 63
Dose-response of neurons to SU1498 and Flt-1-Fc. Neurons were exposed to increasing concentrations of the VEGFR2 inhibitor SU1498 (A) or the decoy VEGFR1 Flt-1-Fc (B). SU1498 was cytotoxic at concentrations of 50 and 100 microM, but not at 10 microM which was the dose used in our experiments (A). A toxic dose of Flt-1-Fc was not determined (B).
###end p 63
###begin p 64
(0.22 MB TIF)
###end p 64
###begin p 65
Click here for additional data file.
###end p 65
###begin p 66
NSPC response to inhibition of autocrine VEGF. Embryonic NSPCs were exposed to the VEGFR1 decoy Flt-1-Fc (1 microg/mL). Flt-1-Fc did not impair the viability of eNSPCs, and did not impair their ability to survive OGD.
###end p 66
###begin p 67
(0.16 MB TIF)
###end p 67
###begin p 68
Click here for additional data file.
###end p 68
###begin p 69
NSPC viability in response to 2 hr OGD. Deletion of exon 2 of the HIF-1alpha gene did not impair eNSPC ability to survive 2 hr OGD, as compared to wild-type eNSPCs.
###end p 69
###begin p 70
(0.14 MB TIF)
###end p 70
###begin p 71
Click here for additional data file.
###end p 71
###begin p 72
Confocal images were generated using the University of New Mexico Cancer Center Fluorescence Microscopy Facility, supported as detailed at . The authors thank Tamara Roitbak, Patrick B. Ventura and Kelsey Thomas for outstanding technical assistance.
###end p 72
###begin title 73
References
###end title 73
###begin article-title 74
###xml 26 31 <span type="species:ncbi:9606">human</span>
Neurogenesis in the adult human hippocampus.
###end article-title 74
###begin article-title 75
Mammalian neural stem cells.
###end article-title 75
###begin article-title 76
A niche for adult neural stem cells.
###end article-title 76
###begin article-title 77
For the long run: maintaining germinal niches in the adult brain.
###end article-title 77
###begin article-title 78
Stem cells in the central nervous system.
###end article-title 78
###begin article-title 79
The development of neural stem cells.
###end article-title 79
###begin article-title 80
A stem cell molecular signature.
###end article-title 80
###begin article-title 81
###xml 110 113 <span type="species:ncbi:10116">rat</span>
Neurogenesis in dentate subgranular zone and rostral subventricular zone after focal cerebral ischemia in the rat.
###end article-title 81
###begin article-title 82
###xml 48 53 <span type="species:ncbi:9606">human</span>
Evidence for stroke-induced neurogenesis in the human brain.
###end article-title 82
###begin article-title 83
###xml 109 112 <span type="species:ncbi:10116">rat</span>
Proliferation and differentiation of progenitor cells in the cortex and the subventricular zone in the adult rat after focal cerebral ischemia.
###end article-title 83
###begin article-title 84
Neuronal replacement from endogenous precursors in the adult brain after stroke.
###end article-title 84
###begin article-title 85
###xml 0 3 <span type="species:ncbi:10116">Rat</span>
Rat forebrain neurogenesis and striatal neuron replacement after focal stroke.
###end article-title 85
###begin article-title 86
Temporal profile of stem cell division, migration, and differentiation from subventricular zone to olfactory bulb after transient forebrain ischemia in gerbils.
###end article-title 86
###begin article-title 87
Subventricular zone-derived neuroblasts migrate and differentiate into mature neurons in the post-stroke adult striatum.
###end article-title 87
###begin article-title 88
Proliferating progenitor cells: a required cellular element for induction of ischemic tolerance in the brain.
###end article-title 88
###begin article-title 89
###xml 28 33 <span type="species:ncbi:9606">human</span>
###xml 53 61 <span type="species:ncbi:9606">patients</span>
Transplantation of cultured human neuronal cells for patients with stroke.
###end article-title 89
###begin article-title 90
Neurogenesis in the adult ischemic brain: generation, migration, survival, and restorative therapy.
###end article-title 90
###begin article-title 91
Regulation of stroke-induced neurogenesis in adult brain--recent scientific progress.
###end article-title 91
###begin article-title 92
Stem cells for ischemic brain injury: a critical review.
###end article-title 92
###begin article-title 93
Tumor vascular permeability factor stimulates endothelial cell growth and angiogenesis.
###end article-title 93
###begin article-title 94
Vascular endothelial growth factor (VEGF) stimulates neurogenesis in vitro and in vivo.
###end article-title 94
###begin article-title 95
Vascular endothelial growth factor: basic science and clinical progress.
###end article-title 95
###begin article-title 96
Vascular endothelial growth factor induced by hypoxia may mediate hypoxia-initiated angiogenesis.
###end article-title 96
###begin article-title 97
Targeting HIF-1 for cancer therapy.
###end article-title 97
###begin article-title 98
HIF-independent regulation of VEGF and angiogenesis by the transcriptional coactivator PGC-1alpha.
###end article-title 98
###begin article-title 99
Hypoxia inducible factor-1 independent pathways in tumor angiogenesis.
###end article-title 99
###begin article-title 100
Current insights on the biology and clinical aspects of VEGF regulation.
###end article-title 100
###begin article-title 101
MiRNA-directed regulation of VEGF and other angiogenic factors under hypoxia.
###end article-title 101
###begin article-title 102
Molecular regulation of the VEGF family -- inducers of angiogenesis and lymphangiogenesis.
###end article-title 102
###begin article-title 103
VEGF-induced neuroprotection, neurogenesis, and angiogenesis after focal cerebral ischemia.
###end article-title 103
###begin article-title 104
###xml 20 35 <span type="species:ncbi:10090">transgenic mice</span>
VEGF-overexpressing transgenic mice show enhanced post-ischemic neurogenesis and neuromigration.
###end article-title 104
###begin article-title 105
###xml 19 24 <span type="species:ncbi:9606">human</span>
Transplantation of human neural stem cells protect against ischemia in a preventive mode via hypoxia-inducible factor-1alpha stabilization in the host brain.
###end article-title 105
###begin article-title 106
###xml 19 24 <span type="species:ncbi:9606">human</span>
###xml 158 162 <span type="species:ncbi:10116">rats</span>
Transplantation of human neural precursor cells in Matrigel scaffolding improves outcome from focal cerebral ischemia after delayed postischemic treatment in rats.
###end article-title 106
###begin article-title 107
Primate embryonic stem cell-derived neuronal progenitors transplanted into ischemic brain.
###end article-title 107
###begin article-title 108
Neural stem/progenitor cells promote endothelial cell morphogenesis and protect endothelial cells against ischemia via HIF-1alpha-regulated VEGF signaling.
###end article-title 108
###begin article-title 109
BID mediates neuronal cell death after oxygen/glucose deprivation and focal cerebral ischemia.
###end article-title 109
###begin article-title 110
Tissue inhibitor of metalloproteinases-3 facilitates Fas-mediated neuronal cell death following mild ischemia.
###end article-title 110
###begin article-title 111
Hypoxia-inducible factor-1alpha is a positive factor in solid tumor growth.
###end article-title 111
###begin article-title 112
###xml 42 45 <span type="species:ncbi:10116">rat</span>
VEGF and flt. Expression time kinetics in rat brain infarct.
###end article-title 112
###begin article-title 113
VEGF mRNA and its receptor flt-1 are expressed in reactive astrocytes following neural grafting and tumor cell implantation in the adult CNS.
###end article-title 113
###begin article-title 114
Angiogenesis in ischemic disease.
###end article-title 114
###begin article-title 115
From angiogenesis to neuropathology.
###end article-title 115
###begin article-title 116
VEGF enhances angiogenesis and promotes blood-brain barrier leakage in the ischemic brain.
###end article-title 116
###begin article-title 117
Vascular endothelial growth factor and angiopoietins in neurovascular regeneration and protection following stroke.
###end article-title 117
###begin article-title 118
Vascular and neuronal effects of VEGF in the nervous system: implications for neurological disorders.
###end article-title 118
###begin article-title 119
TNF receptor I sensitizes neurons to erythropoietin- and VEGF-mediated neuroprotection after ischemic and excitotoxic injury.
###end article-title 119
###begin article-title 120
Paracrine and autocrine functions of neuronal vascular endothelial growth factor (VEGF) in the central nervous system.
###end article-title 120
###begin article-title 121
Neurotrophic effects of vascular endothelial growth factor on organotypic cortical explants and primary cortical neurons.
###end article-title 121
###begin article-title 122
Vascular endothelial growth factor: direct neuroprotective effect in in vitro ischemia.
###end article-title 122
###begin article-title 123
The phosphatidylinositol-3 kinase/Akt pathway mediates VEGF's neuroprotective activity and induces blood brain barrier permeability after focal cerebral ischemia.
###end article-title 123
###begin article-title 124
Caspase-3 and the regulation of hypoxic neuronal death by vascular endothelial growth factor.
###end article-title 124
###begin article-title 125
Coupling of angiogenesis and neurogenesis in cultured endothelial cells and neural progenitor cells after stroke.
###end article-title 125
###begin article-title 126
Neural progenitor cells treated with EPO induce angiogenesis through the production of VEGF.
###end article-title 126
###begin article-title 127
Neural stem/progenitor cells initiate the formation of cellular networks that provide neuroprotection by growth factor-modulated antioxidant expression.
###end article-title 127
###begin article-title 128
Biology of HIF-1alpha.
###end article-title 128
###begin article-title 129
Hsp90 regulates a von Hippel Lindau-independent hypoxia-inducible factor-1 alpha-degradative pathway.
###end article-title 129
###begin article-title 130
Heat shock protein 90 is involved in regulation of hypoxia-driven proliferation of embryonic neural stem/progenitor cells.
###end article-title 130
###begin article-title 131
###xml 76 80 <span type="species:ncbi:10090">mice</span>
A potential role for erythropoietin in focal permanent cerebral ischemia in mice.
###end article-title 131
###begin article-title 132
BCL-xL is a target gene regulated by hypoxia-inducible factor-1{alpha}.
###end article-title 132
###begin article-title 133
###xml 98 101 <span type="species:ncbi:10116">rat</span>
Induction of hypoxia-inducible factor-1 (HIF-1) and its target genes following focal ischaemia in rat brain.
###end article-title 133
###begin article-title 134
Hypoxia requires notch signaling to maintain the undifferentiated cell state.
###end article-title 134
###begin article-title 135
###xml 162 165 <span type="species:ncbi:10116">rat</span>
In vitro hypoxic preconditioning of embryonic stem cells as a strategy of promoting cell survival and functional benefits after transplantation into the ischemic rat brain.
###end article-title 135
###begin article-title 136
Endogenous erythropoietin signaling is required for normal neural progenitor cell proliferation.
###end article-title 136
###begin article-title 137
Erythropoietin regulates the in vitro and in vivo production of neuronal progenitors by mammalian forebrain neural stem cells.
###end article-title 137
###begin article-title 138
A critical role of erythropoietin receptor in neurogenesis and post-stroke recovery.
###end article-title 138
###begin article-title 139
###xml 80 83 <span type="species:ncbi:10116">rat</span>
Role of vascular endothelial growth factor in neuronal DNA damage and repair in rat brain following a transient cerebral ischemia.
###end article-title 139
###begin article-title 140
###xml 105 110 <span type="species:ncbi:9606">human</span>
The postischemic environment differentially impacts teratoma or tumor formation after transplantation of human embryonic stem cell-derived neural progenitors.
###end article-title 140
###begin article-title 141
Proliferation, differentiation, and long-term culture of primary hippocampal neurons.
###end article-title 141
###begin article-title 142
Angiogenic recruitment of pericytes from bone marrow after stroke.
###end article-title 142
###begin article-title 143
Lack of hypoxia-inducible factor-1 alpha impairs midbrain neural precursor cells involving vascular endothelial growth factor signaling.
###end article-title 143
###begin p 144
###xml 0 21 0 21 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Competing Interests: </bold>
Competing Interests: The authors have declared that no competing interests exist.
###end p 144
###begin p 145
###xml 0 9 0 9 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Funding: </bold>
Funding: This work was supported by grants from the American Heart Association (), 0810071Z (KMH) and 09GRNT2290178 (LAC), and Dedicated Health Research Funds from the University of New Mexico School of Medicine (), C-2310-RAC/Bridge (LAC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
###end p 145

